Successful Desensitization to Sorafenib and Imatinib-A Report of Two Cases and a Literature Review.
Natasa KusicVesna Tomic SpiricSnezana ArandjelovicAleksandra Peric PopadicIvana Bozic AnticMilan DimitrijevicRada MiskovicLjiljana StefanovicAleksandra PlavsicPublished in: Healthcare (Basel, Switzerland) (2024)
Desensitization to sorafenib and imatinib can be an effective therapeutic option in patients with hypersensitivity to those medications, without alternative treatment options.